‘I was white-knuckling it’: Philadelphia patients are still struggling to get ADHD meds amid years-long shortage
Researchers and clinicians say the shortage is due to limits on manufacturing and sales of the medications, and supply chain problems.
Other Articles in this Edition
Disability Groups Fear RFK Jr.’s New Special Education Role
Adult Misuse of ADHD Stimulants Declines but Remains a Public Health Concern
Longer breastfeeding links to fewer ADHD symptoms in children
Meta-analysis: Cognitive Behavioral Therapy for Adult ADHD
Some employers are creating neurodivergent-friendly spaces to help all workers thrive
Designing Personalized ADHD-Friendly Systems
Blueberries may boost children’s memory and mood
Viloxazine Reduces Symptoms for ADHD and Comorbid Depression and Anxiety
Scientists discover ancient brain cells that help block
ADHD prescription stimulant use linked to other drug use, UQ study finds